Flagship Pioneering has announced the formation of Etcelera, a company created by the merger of the platforms of Cellarity, Etiome and Empress Therapeutics.  The new company aims to pioneer causal intelligence in human biology: the ability to determine what truly drives disease and predict how a medicine will act in patients before it reaches the […]